标题
Ketorolac salt is a newly discovered DDX3 inhibitor to treat oral cancer
作者
关键词
-
出版物
Scientific Reports
Volume 5, Issue 1, Pages -
出版商
Springer Nature
发表日期
2015-04-28
DOI
10.1038/srep09982
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Tumour Hypoxia Affects the Responsiveness of Cancer Cells to Chemotherapy and Promotes Cancer Progression
- (2012) Jean-Philippe Cosse et al. Anti-Cancer Agents in Medicinal Chemistry
- NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: particular relevance to triple negative subgroup
- (2012) Michael Retsky et al. BREAST CANCER RESEARCH AND TREATMENT
- Stability indicating HPLC method for the simultaneous determination of moxifloxacin and prednisolone in pharmaceutical formulations
- (2012) Syed Naeem Razzaq et al. Chemistry Central Journal
- Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells
- (2012) Toni Celià-Terrassa et al. JOURNAL OF CLINICAL INVESTIGATION
- Expression of DDX3 Is Directly Modulated by Hypoxia Inducible Factor-1 Alpha in Breast Epithelial Cells
- (2011) Mahendran Botlagunta et al. PLoS One
- A Motif Unique to the Human Dead-Box Protein DDX3 Is Important for Nucleic Acid Binding, ATP Hydrolysis, RNA/DNA Unwinding and HIV-1 Replication
- (2011) Anna Garbelli et al. PLoS One
- Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity
- (2011) R. Dash et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Novel, Broad Spectrum Anticancer Agents Containing the Tricyclic 5:7:5-Fused Diimidazodiazepine Ring System
- (2011) Atul Kondaskar et al. ACS Medicinal Chemistry Letters
- Studies on the anti-hepatitis C virus activity of newly synthesized tropolone derivatives: Identification of NS3 helicase inhibitors that specifically inhibit subgenomic HCV replication
- (2010) Andżelika Najda-Bernatowicz et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Challenges associated with identifying the environmental determinants of the inflammatory bowel diseases
- (2010) Natalie A. Molodecky et al. INFLAMMATORY BOWEL DISEASES
- Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field
- (2010) Devleena Shivakumar et al. Journal of Chemical Theory and Computation
- Promoting assembly and bundling of FtsZ as a strategy to inhibit bacterial cell division: a new approach for developing novel antibacterial drugs
- (2009) Tushar K. Beuria et al. BIOCHEMICAL JOURNAL
- Targeting Mammalian Target of Rapamycin by Rapamycin Prevents Tumor Progression in an Oral-Specific Chemical Carcinogenesis Model
- (2009) R. Czerninski et al. Cancer Prevention Research
- Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype
- (2008) D. Sarrio et al. CANCER RESEARCH
- Identification of an antiapoptotic protein complex at death receptors
- (2008) M Sun et al. CELL DEATH AND DIFFERENTIATION
- Pharmacophore Modeling and Molecular Docking Led to the Discovery of Inhibitors of Human Immunodeficiency Virus-1 Replication Targeting the Human Cellular Aspartic Acid−Glutamic Acid−Alanine−Aspartic Acid Box Polypeptide 3
- (2008) Giovanni Maga et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ring Expanded Nucleoside Analogues Inhibit RNA Helicase and Intracellular Human Immunodeficiency Virus Type 1 Replication
- (2008) Venkat S. R. K. Yedavalli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- Oncogenic role of DDX3 in breast cancer biogenesis
- (2008) M Botlagunta et al. ONCOGENE
- The First Synthesis of a Novel 5:7:5-Fused Diimidazodiazepine Ring System and Some of Its Chemical Properties
- (2008) Raj Kumar et al. ORGANIC LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started